Gianluca Pirozzi
Director/Board Member at TREX WIND-DOWN, INC.
Net worth: 1 $ as of 31/03/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ed Sitar | M | 63 | 4 years | |
Sean Christie | M | - | 3 years | |
Lubor Gaal | M | 56 | 4 years | |
Piyush Sharma | M | - | 7 years | |
David Cohen | M | 59 | 4 years | |
Sarah Marshall | F | - | 10 years | |
Christophe Hotermans | M | - | 4 years | |
Ruth Diazaraque | M | - | 1 years | |
Seng Cheng | M | - | 1 years | |
Jessica Bruno-Raiz | F | - | 5 years | |
Glen Frick | M | 57 | - | |
Nicola Heffron | F | 52 | 1 years | |
Morgan Sanford | F | - | - | |
Tamar Thompson | F | 50 | 5 years | |
Patryk Mikucki | M | 49 | - | |
Frédéric Chéreau | M | 57 | 2 years | |
Marc Dunoyer | M | 71 | - | |
Todd Spalding | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Brennan | M | 70 | 7 years | |
Zachary Rome | M | 40 | 2 years | |
John Koconis | M | 54 | 4 years | |
Joe Lucchese | M | 57 | 4 years | |
Felix Baker | M | 55 | 6 years | |
Rana Strellis | F | - | 4 years | |
Christopher Coughlin | M | 71 | 7 years | |
Susan Altschuller | M | 42 | 2 years | |
Michael T. Stocum | M | 58 | - | |
Scott Peters | M | - | 8 years | |
Michael Ira Kenneth Elloian | M | 52 | - | |
Ludwig Hantson | M | 61 | 4 years | |
Ebun Garner | M | 52 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 years |
Jack Mollen | M | 73 | 7 years | |
Brian Goff | M | 55 | 4 years | |
Judith Reinsdorf | F | 60 | 3 years | |
Paul Friedman | M | 81 | 4 years | |
Anne-Marie Law | F | 56 | 3 years | |
Ellen Chiniara | F | 65 | 3 years | |
Francois Nader | M | 67 | 4 years | |
Deborah Dunsire | M | 61 | 3 years | |
Linda A. Broenniman | F | 67 | - | |
Andreas Rummelt | M | 66 | 11 years | |
Thierry Chauche | M | 48 | 1 years | |
Ai Min Hui | M | 61 |
Sanofi SA
| 2 years |
Angela Giannantonio | F | - | - | |
Shane Doyle | M | - | 7 years | |
Megan Goulart | F | - | - | |
Kristen Stants | F | 51 | 2 years | |
Adam Hansard | M | 48 | 1 years | |
Christopher Wick | M | - | 4 years | |
Alexandra Kropotova | M | 51 |
Sanofi SA
| 9 years |
Christopher Sorli | M | - |
Sanofi SA
| 4 years |
Uzair Qadeer | M | - | 2 years | |
Becky Lillie | F | - | - | |
Rosemary Harrison | M | 41 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 years |
Alan Mendelsohn | M | 62 | 3 years | |
Julia Wang | F | 53 | 2 years | |
Martine Zimmermann | M | 55 | 7 years | |
Holly Schachner | M | 57 |
Sanofi SA
| 5 years |
Sandra Jonsson | M | 51 | - | |
Christopher Benecchi | M | - | 2 years | |
Michael Lisjak | M | 50 |
Sanofi SA
| 1 years |
Patrick Barry | M | - |
Sanofi SA
| 24 years |
Ann Miller | M | 66 |
Sanofi SA
| 6 years |
Amir Tavakkol | M | 69 | 1 years | |
Paul Sekhri | M | 65 |
Sanofi SA
| 1 years |
Heidi Henson | F | 58 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 years |
Laurie Keating | F | 70 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | 1 years |
Christopher J. Stevo | M | - | 1 years | |
Michael Derby | M | 51 | 2 years | |
Paul Clancy | M | 62 | 2 years | |
Emmanuel Babeau | M | 57 |
Sanofi SA
| 2 years |
Steven M. Bosacki | M | 66 | - | |
Tanisha Cariño | M | 49 | 2 years | |
Indrani Franchini | F | 52 | 4 years | |
H. Cohen | M | 58 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | - |
John V. W. Reynders | M | - | 6 years | |
Vincent O'Neill | M | 55 |
Sanofi SA
| 2 years |
John Orloff | M | 66 | 4 years | |
Dieter Weinand | M | 63 |
Sanofi SA
| 2 years |
Jose Menoyo | M | - | 3 years | |
Desiree Luthman | M | 65 |
Sanofi SA
| 2 years |
Ching Jaw | M | 61 |
Sanofi SA
| 2 years |
Michael Kaseta | M | 48 |
Sanofi SA
| 11 years |
Daniel A. Bazarko | M | - | 9 years | |
Tsveta Milanova | F | 47 | 2 years | |
Laura Gault | F | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 72 | 83.72% |
France | 14 | 16.28% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gianluca Pirozzi
- Personal Network